**2. Materials and Methods**

This is a retrospective analysis using the electronic medical record. A total of 30 kidney transplant patients with a new diagnosis of COVID-19 as confirmed by PCR testing were included in this analysis. Patients were diagnosed between 31 March 2020—4 September 2020. Remdesivir was indicated in all patients for a (+) COVID-19 PCR and symptoms requiring presentation to receive care per clinical judgement of the transplant nephrologist. Serial PCR results were followed from the time of diagnosis and then every 2–4 weeks until becoming negative. Student's T-testing was performed on parametric continuous data, and Wilcoxon Signed Rank testing was employed when data were not guaranteed to be parametric. The chi-square or fisher's exact test was used for categorical data. Statistical analysis was performed using JMP PRO version 15.0.
